Geoffrey S Dow's most recent trade in 60 Degrees Pharmaceuticals Inc was a trade of 4,376 Common Stock done at an average price of $3.0 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.99 per share. | 09 Jun 2025 | 4,376 | 26,171 | - | 3.0 | 13,065 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 14,394 | 108,974 | - | 0 | Common Stock | |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 525,000 | 525,000 | - | - | Stock Option (Right to Buy) | |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 05 Dec 2024 | 35,823 | 94,580 | - | 1.3 | 45,563 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 05 Dec 2024 | 20,579 | 58,757 | - | 1.2 | 24,672 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.11 per share. | 05 Dec 2024 | 17,549 | 38,178 | - | 1.1 | 19,520 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 19 Nov 2024 | 3,500 | 20,629 | - | 0.9 | 3,195 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 19 Nov 2024 | 2,500 | 16,129 | - | 0.9 | 2,248 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 19 Nov 2024 | 1,000 | 17,129 | - | 0.9 | 924 | Common Stock |
| 60 Degrees Pharmaceuticals... | Dow Geoffrey S. | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 31 Jan 2024 | 25,974 | 703,599 | - | 0.4 | 9,740 | Common Stock |
| 60 Degrees Pharmaceuticals... | S. Dow Geoffrey | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jan 2024 | 25,974 | 25,974 | - | - | Warrant | |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2023 | 85,000 | 85,000 | - | - | Restricted Stock Units | |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.27 per share. | 21 Nov 2023 | 68,000 | 745,625 | - | 0.3 | 18,142 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2023 | 68,000 | 17,000 | - | - | Restricted Stock Units | |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.22 per share. | 21 Nov 2023 | 17,000 | 762,625 | - | 0.2 | 3,791 | Common Stock |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2023 | 17,000 | 0 | - | - | Restricted Stock Units | |
| 60 Degrees Pharmaceuticals... | Geoffrey S. Dow | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 300,000 | 300,000 | - | - | Non-Qualified Stock Option (right to buy) |